May. 10, 2019—Staff from the Center for Cognitive Medicine will administer memory screenings and Alzheimer’s gene screenings at no cost to community members ages 60 and above.
Feb. 12, 2019—Center for Cognitive Medicine offering Alzheimer's APOE4 Gene Screening at Whole Foods on Feb. 18.
Jan. 4, 2019—The Center for Cognitive Medicine is seeking volunteers ages 65-75 who have not been diagnosed with any memory impairment and are interested in whether their genetics show they are at increased risk of Alzheimer’s disease.
Sep. 4, 2018—Interested in the treatments and prevention of Alzheimer's disease? The Center for Cognitive Medicine is hosting an open house and screening event on Sept. 7.
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
Jul. 13, 2016—Do you have a loved one with Alzheimer’s disease or dementia? Are you looking for ways to communicate when words are lost?
Apr. 28, 2016—Higher genomic levels of African ancestry are associated with an increased risk for Alzheimer’s disease, a consortium of investigators reported recently in Alzheimer’s & Dementia.
Mar. 11, 2016—Are you caring for a loved one with Alzheimer’s disease or dementia? Have you ever wondered what life is like for him or her? If you’d like to learn more, sign up for the Vanderbilt Child & Family Center’s Virtual Dementia Tour on April 20.
Oct. 29, 2015—Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.